Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00746733 · ClinicalTrials.gov registry record · Phase 1
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
A Phase 1 study, sponsored by Shire.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00746733 is a Phase 1 study that has completed, run by Shire. The registered enrollment target is 24 participants.
The verdict
NCT00746733, a Phase 1 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if taking Vyvanse with Prilosec OTC or Adderall XR with Prilosec OTC changes how quickly the drug is absorbed into the body and/or changes how much of the drug is absorbed into the body.
Interventions
- DRUG Adderall XR (mixed salts amphetamine)
- DRUG Lisdexamfetamine Dimesylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-09-08 |
| Est. Completion | 2008-10-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00746733
The ClinicalTrials.gov registry entry for NCT00746733 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adderall XR (mixed salts amphetamine) is the first listed.
NCT00746733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00746733 about?
NCT00746733 is a clinical study titled "Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC". The purpose of this study is to determine if taking Vyvanse with Prilosec OTC or Adderall XR with Prilosec OTC changes how quickly the drug is absorbed into the body and/or changes how much of the drug is absorbed into the body.
What is the current status of trial NCT00746733?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-09-08. Estimated completion is 2008-10-26.
What interventions are being tested in trial NCT00746733?
The interventions under investigation include: Adderall XR (mixed salts amphetamine) (DRUG), Lisdexamfetamine Dimesylate (DRUG).
Who is sponsoring clinical trial NCT00746733?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.